McKesson Financial Statements
NYSE: MCKHealth CareOther PharmaceuticalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
McKesson revenue and earnings
In fiscal 2026, McKesson generated $403.43 billion in revenue, up 12.4% from fiscal 2025, its 13th consecutive year of revenue growth. Net income was $4.76 billion (+44.5% year over year), for a net margin of 1.2% versus a median of 0.9% in the prior 5 years. Gross margin was 3.6% (down from 3.7%) and operating margin 1.5%.
Diluted earnings per share came in at $38.38, up from $25.72. Over the last 5 fiscal years, MCK's revenue has grown at a 11.1% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
McKesson income statement (annual)
| Fiscal year (USD) | FY 20262026-03-31 | FY 20252025-03-31 | FY 20242024-03-31 | FY 20232023-03-31 | FY 20222022-03-31 | FY 20212021-03-31 | FY 20202020-03-31 | FY 20192019-03-31 | FY 20182018-03-31 | FY 20172017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 403.43B | 359.05B | 308.95B | 276.71B | 263.97B | 238.23B | 231.05B | 214.32B | 208.36B | 198.53B |
| Revenue growth (YoY) | +12.36% | +16.22% | +11.65% | +4.83% | +10.80% | +3.11% | +7.81% | +2.86% | +4.95% | +4.01% |
| Cost of Revenue | 388.88B | 345.73B | 296.12B | 264.35B | 250.84B | 226.08B | 219.03B | 202.56B | 197.17B | 187.26B |
| Gross Profit | 14.55B | 13.32B | 12.83B | 12.36B | 13.13B | 12.15B | 12.02B | 11.75B | 11.18B | 11.27B |
| Operating Expenses | 8.34B | 8.90B | 8.92B | 7.98B | 11.09B | 17.19B | 9.53B | 10.87B | 10.42B | 4.15B |
| Research & Development | — | — | — | — | — | — | 96.00M | 71.00M | 125.00M | 341.00M |
| Selling, General & Admin | 8.10B | 8.51B | 8.66B | 7.78B | 10.54B | 8.85B | 9.18B | 8.44B | 8.14B | 7.45B |
| Operating Income | 6.21B | 4.42B | 3.91B | 4.38B | 2.04B | -5.04B | 2.49B | 886.00M | 762.00M | 7.12B |
| Interest Expense | 247.00M | 265.00M | 252.00M | 248.00M | 178.00M | 217.00M | 249.00M | 264.00M | 283.00M | 308.00M |
| Other Income (Expense) | 236.00M | 202.00M | 132.00M | 497.00M | 259.00M | 223.00M | 12.00M | 182.00M | 130.00M | 77.00M |
| Pretax Income | 6.20B | 4.36B | 3.79B | 4.63B | 1.93B | -5.03B | 1.14B | 610.00M | 239.00M | 6.89B |
| Income Tax | 1.10B | 878.00M | 629.00M | 905.00M | 636.00M | -695.00M | 18.00M | 356.00M | -53.00M | 1.61B |
| Net Income | 4.76B | 3.29B | 3.00B | 3.56B | 1.11B | -4.54B | 900.00M | 34.00M | 67.00M | 5.07B |
| Net Income growth (YoY) | +44.52% | +9.76% | -15.67% | +219.57% | — | -604.33% | +2547.06% | -49.25% | -98.68% | +124.53% |
| EPS (Basic) | 38.55 | 25.86 | 22.54 | 25.23 | 7.32 | -28.26 | 4.98 | 0.17 | 0.32 | 22.95 |
| EPS (Diluted) | 38.38 | 25.72 | 22.39 | 25.03 | 7.23 | -28.26 | 4.95 | 0.17 | 0.32 | 22.73 |
| Shares Outstanding (Basic) | 123.60M | 127.40M | 133.20M | 141.10M | 152.30M | 160.60M | 180.60M | 196.30M | 208.00M | 221.00M |
| Shares Outstanding (Diluted) | 124.10M | 128.10M | 134.10M | 142.20M | 154.10M | 160.60M | 181.60M | 197.30M | 209.00M | 223.00M |
| EBITDA | 6.50B | 4.69B | 4.19B | 4.65B | 2.35B | -4.70B | 2.82B | 1.20B | 1.71B | 8.03B |
| Gross Margin | 3.61% | 3.71% | 4.15% | 4.47% | 4.97% | 5.10% | 5.20% | 5.48% | 5.37% | 5.68% |
| Operating Margin | 1.54% | 123.00% | 127.00% | 1.58% | 77.00% | -2.12% | 108.00% | 41.00% | 37.00% | 3.59% |
| Net Margin | 118.00% | 92.00% | 97.00% | 129.00% | 42.00% | -1.91% | 39.00% | 2.00% | 3.00% | 2.55% |
This table shows 10 annual periods of McKesson's income statement, from FY 2026 back to FY 2017, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow MCK's reporting calendar. What is a income statement?